Health Effects of Grain Foods in Adults
Purdue University · with Grain Foods Foundation · NCT06339879
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–60 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- January 18, 2024
- Record last updated
- July 15, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will assess the effects of eating whole grain foods versus refined grain foods with different amounts of added sugar. It is hypothesized that a diet including grain products will have beneficial effects on taste hedonics, appetite, food/energy intake, body weight, blood pressure, acute and chronic glycemia and acute and chronic lipemia compared to customary diets controlling for added sugars, saturated fats and sodium.
Being studied: High Whole Grain, Low Sugar; Low Whole Grain, Low Sugar; High Whole Grain, High Sugar; Low Whole Grain, High Sugar
Conditions: High Whole Grain and Low Sugar; Medium Whole Grain and Low Sugar; Low Whole Grain and Low Sugar; Low Whole Grain and High Sugar
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- male and female; 21 to 60 years old; Hemoglobin A1c concentration between 5.7 and 6.4%
- Prefer no use of medications, but if on medication, must have been on a stable dose for 3 months and plan to remain at the same dose for the duration of the trial.
- low customary intake of whole grain foods (less than 2 servings per day) and high energy from added sugar (greater than 10% energy).
Exclusion Criteria
- Grain or dairy sensitivities or allergies or celiac disease; sensitivity or allergy to other foods that would result in refusal to eat a class of foods.
- smoker
- intended weight loss or gain during the study period; intended change of activity level during the study period
- use of blood thinners
- prior gastrointestinal surgery.
Recruiting US locations
Purdue University
West Lafayette, IN 17907
Site contact: Richard D Mattes, PhD · 765-494-0662 · mattes@purdue.edu
Study contacts (from the official record)
- Judy George, BS · 4654946192 · georgej@purdue.edu
- Richard Mattes, PhD · 7654940662 · mattes@purdue.edu
Similar studies in Indiana
All weight loss studies in Indiana →- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Pfizer
- Location
- Evansville, IN + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
AstraZeneca
- Location
- Indianapolis, IN + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Eli Lilly and Company
- Location
- Brownsburg, IN + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Amgen
- Location
- Munster, IN + 136 other US sites
- Eligibility basics
- Ages 45–99